'Orange Book' Changes? US FDA Soliciting Comments On TE Codes

 
• By Derrick Gingery
  
Generics
The FDA also seeks comments on the potential changes to 'Orange Book' patent listing practices. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership